Exploring the differences in performance measurement between research and development: evidence from a multiple case study

Researchers and practitioners have recently paid great attention to research and development (R&D) performance measurement, although it is acknowledged to be a very challenging task because of R&D intrinsic uncertainty and complexity levels. In this paper, the problem of designing a performance measurement system (PMS) for R&D activities is addressed; specifically, we investigate if and how the design of the PMS is influenced by the type of activity it is applied to, namely Basic and Applied Research or new product development (NPD). We first develop a theoretical framework that comprises the main constitutive elements of a PMS for R&D. Then the framework is used for supporting a multiple case study analysis involving eight Italian technology-intensive firms. The research results show that the criteria for designing the constitutive elements of the PMS are radically different in Basic and Applied Research and NPD. The reasons behind the observed dissimilarities in the design criteria are widely discussed in the paper, as well as their implications for R&D managers.     

Trading with a common agent under complete information: A characterization of Nash equilibria

We analyze an abstract model of trading where N principals submit quantity-payment schedules that describe the contracts they offer to an agent, and the agent then chooses how much to trade with every principal. This represents a special class of common agency games with complete information. We study all the subgame perfect Nash equilibria of these games, not only truthful ones, providing a complete characterization of equilibrium payoffs. In particular, we show that the equilibrium that is Pareto-dominant for the principals is not truthful when there are more than two of them. We also provide a partial characterization of equilibrium strategies.     

The Open Innovation Journey: How firms dynamically implement the emerging innovation management paradigm

Open Innovation is currently one of the most debated topics in management literature. Nevertheless, there are still many unanswered questions in Open Innovation research. Especially two issues require further investigation: (i) understanding the relevance of Open Innovation beyond high-tech industries and (ii) studying how firms implement Open Innovation in practice. The paper addresses these topics by studying, through an in-depth case study, the journey that the Italian leading cement manufacturer, has undergone to move from a Closed to an Open Innovation paradigm.The paper shows that the Open Innovation paradigm is implemented along a three-phase process that comprises the stages of unfreezing, moving and institutionalising. Moreover, it emerges that the changes through which Open Innovation has been implemented involve four major dimensions, i.e. networks, organisational structures, evaluation processes and knowledge management systems. They should be therefore conceived as the managerial and organisational levers an innovating firm can act upon to streamline its journey toward Open Innovation. Theoretical and managerial implications of using these levers for implementing Open Innovation are discussed at length.     

Exploring the role of human resources in technology out-licensing:an empirical analysis of biotech newtechnology-based firms

Out-licensing is a technology exploitation option to generate revenues without investing in downstream complementary assets. Despite its increasing strategic relevance, the strong complexity of out-licensing activity determines a substantial discrepancy in firms’ ability to extract monetary benefits from this practice. Searching for determinants of out-licensing performance, the paper focuses in particular on the role of licensing managers. Based on a multiple case study analysis involving 26 out-licensing deals executed in seven Italian biotech NTBFs, the study shows that expert scientific skills, extensive licensing practice and prior employment in multinationals, but not an intense social network, characterise successful licensing managers, while high delegation and powerful intrinsic rewards enable individual capacities of licensing managers to translate into actual economic value.     

R&D Corporate Planning: Selecting the Core Technological Competencies

This paper deals with the selection of a firm's technological competencies on which to concentrate development efforts in a long term view. The perspective is that of corporate R&D which has to identify the technological competencies relevant to future competition and select those core for the firm. This process faces a major challenge, especially to put together different issues relevant to the problem: identify future scenarios and predict how new industries will be shaped, evaluate the potential of future markets, estimate the role and relevance of the technologies involved, identify a balanced set of technologies. This paper proposes a comprehensive methodology to support the process of selection of core technological competencies.     

Network of Collaborations for Innovation: The Case of Biotechnology

The ‘life science’ revolution related to the development of biotechnology affects many different markets. In the pharmaceutical business new drugs are continuously developed, tested, and submitted to governmental institutions for the required approval. In the agricultural business the so-called ‘green revolution’ is well under way with many new products designed in order to appeal to farmers or to consumers. The increasing pace of introduction of new biotech products—particularly drugs and agrochemical (Ag) foods—leads firms to look for collaborations in the different phases of the introduction process. Basing on an empirical study conducted on a sample of 27 organisations involved in the process of introduction of biotech products, the paper aims at comparing and contrasting the nature and the processes involved in inter-institutional collaborations occurring at various stages of new product development and commercialisation of new biotech products (particularly drugs and Ag foods).     

Exploitation and diffusion of public research: the case of academic spin‐off companies in Italy

Scientific and technological knowledge is considered the most important raw material for economic growth. The attention on the exploitation of public research, undoubtedly one of the main sources of new scientific and technological knowledge, has increased in recent years. After reviewing some concepts regarding the exploitation of public research results, the paper focuses on the analysis of academic spin‐off companies as one of the most promising ways to transfer research results to the market place. The phenomenon of academic spin‐off companies is described using both international evidence and a recent survey regarding 48 Italian spin‐off companies.     

Performance measurement in R&D: exploring the interplay between measurement objectives, dimensions of performance and contextual factors

Measuring research and development (R&D) performance has become a fundamental concern for R&D managers and executives in the last decades. As a result, the issue has been extensively debated in innovation and R&D management literature. The paper contributes to this growing body of knowledge, adopting a systemic and contextual perspective to look into the problem of measuring R&D performance. In particular, it explores the interplay between measurement objectives, performance dimensions and contextual factors in the design of a performance measurement system (PMS) for R&D activities. The paper relies on a multiple case study analysis that involved 15 Italian technology-intensive firms. The results indicate that firms measure R&D performance with different purposes, i.e. motivate researchers and engineers, monitor the progress of activities, evaluate the profitability of R&D projects, favour coordination and communication and stimulate organisational learning. These objectives are pursued in clusters, and the importance firms attach to each cluster is influenced by the context (type of R&D, industry belonging, size) in which measurement takes place. Furthermore, a firm's choice to measure R&D performance along a particular perspective (i.e. financial, customer, business processes or innovation and learning) is influenced by the classes of objectives (diagnostic, motivational or interactive) that are given higher priority. The implications of these results for R&D managers and scholars are discussed in the paper.     

Optimal credit risk transfer, monitored finance, and banks

We examine the implications of optimal credit risk transfer (CRT) for bank-loan monitoring, and the incentives for banks to engage in optimal CRT. In our model, properly designed CRT instruments allow banks to insure themselves against loan losses precisely in those states that signal monitoring. We find that optimal CRT enhances loan monitoring and expands financial intermediation, in contrast to the findings of the previous literature. Optimal CRT instruments are based on loan portfolios rather than individual loans and have credit-enhancement guarantees, pretty much as banks do in practice. But the extent of credit enhancement needs to be precisely delimited. Above that exact level, monitoring incentives are undermined (loan quality deteriorates) and wealth is transferred from the bank's financiers to the bank. Properly designed risk-based capital requirements are shown to prevent such a wealth transfer and to provide banks with the incentive to engage in optimal CRT.